These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2150026
1. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study]. Andreozzi GM, Lepore R. Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026 [Abstract] [Full Text] [Related]
2. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study]. Minerva Med; 1985 Oct 13; 76(39):1803-11. PubMed ID: 4047463 [Abstract] [Full Text] [Related]
3. Buflomedil in arterial occlusive disease: results of a controlled multicenter study. Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W. Angiology; 1984 Aug 13; 35(8):500-5. PubMed ID: 6383127 [Abstract] [Full Text] [Related]
4. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy]. Paoletti V, Mammarella A, Alessandrini A, Barlattani M. Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843 [No Abstract] [Full Text] [Related]
5. [Buflomedil in arterial occlusive disease. Results of a controlled study]. Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W. Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854 [No Abstract] [Full Text] [Related]
6. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs]. Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V. Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536 [No Abstract] [Full Text] [Related]
7. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs]. Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F. Minerva Cardioangiol; 1986 Nov 30; 34(11):745-9. PubMed ID: 2949163 [No Abstract] [Full Text] [Related]
8. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs]. Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P. Ann Radiol (Paris); 1994 Nov 30; 37(3):239-44. PubMed ID: 8092756 [Abstract] [Full Text] [Related]
9. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication. Van den Brande P, Maurel A. Angiology; 1998 Feb 30; 49(2):105-14. PubMed ID: 9482510 [Abstract] [Full Text] [Related]
10. [Effects of buflomedil on peripheral arteriopathies. An open clinical study]. Longo FN, Potortì F, Urbano O, Perroni GB. Minerva Cardioangiol; 1988 May 30; 36(5):249-52. PubMed ID: 3059229 [No Abstract] [Full Text] [Related]
11. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T. J Int Med Res; 1984 May 30; 12(3):188-92. PubMed ID: 6734922 [No Abstract] [Full Text] [Related]
12. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs]. Warembourg G, Carre A, Ginestet A, Lambert M. Lille Med; 1976 Dec 30; 21 Suppl 4():898-901. PubMed ID: 1018614 [No Abstract] [Full Text] [Related]
13. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs]. Petruzzellis V, Scardigno A, Coviello C. Minerva Med; 1982 Feb 11; 73(5):181-6. PubMed ID: 7038552 [Abstract] [Full Text] [Related]
14. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication]. Diehm C, Eckstein M, Hübsch-Müller C. Vasa; 1989 Feb 11; 18(1):40-7. PubMed ID: 2648691 [Abstract] [Full Text] [Related]
15. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution]. Visconti W, Grillo N. Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842 [Abstract] [Full Text] [Related]
16. [Intermittent claudication: topical treatment with isosorbide dinitrate ointment. Preliminary results]. Biagini A, Carpeggiani C, Testa R, Mazzei MG, Michelassi C, L'Abbate A. G Ital Cardiol; 1981 May 12; 11(7):983-9. PubMed ID: 7308655 [Abstract] [Full Text] [Related]
17. [Buflomedil chlorhydrate in peripheral vasculopathies]. Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S. Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055 [No Abstract] [Full Text] [Related]
18. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study]. Trübestein G, Trübestein R, Ludwig M. Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437 [Abstract] [Full Text] [Related]
19. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R. J Int Med Res; 1985 Dec 20; 13(6):317-21. PubMed ID: 4076530 [Abstract] [Full Text] [Related]
20. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V. Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]